Fluidigm Developing Assay Panels for Gene Expression Studies in Single Stem Cells
May 20, 2010
Fluidigm Developing Assay Panels for Gene Expression Studies in Single Stem Cells
Fluidigm is now seeking stem cell researchers with which to collaborate to beta-test and provide feedback on the gene expression panels prior to an anticipated broad product launch later this year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Fluidigm Taps Eisenberg Brothers as Israeli Distributor
February 24, 2011 / PCR Insider - Amid Plans for $86.3M IPO, Fluidigm Discloses Novartis Prenatal Dx Deal
December 9, 2010 / PCR Insider - Fluidigm Seeks to Retain Lead in Burgeoning dPCR Market with Higher-Density Chip Offerings
August 19, 2010 / PCR Insider - Fluidigm Eyes 25 Single-Cell Prep System Placements via Early Access as Q1 Revenues Spike 22 Percent
August 9, 2012 / PCR Insider - Life Tech, Douglas Scientific Pact Expands Ag Bio Market, Opens Up New Arenas for Both Firms
July 19, 2012 / PCR Insider